Immunocytochemistry / Immunofluorescence analysis of
human cardiac stem cells labeling Ki67 with ab16667 at 1/250 dilution.
Human cardiac stem cells.
Heart Repair Using Nanogel - Encapsulated
Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction.
In lab experiments, the researchers isolated exosomes from specialized
human cardiac stem cells and found that exosomes alone had the same beneficial effects as stem cells.
Not exact matches
This image shows an implanted graft of
cardiac cells derived from
human stem cells (green) meshed and beat with primates» heart cells (red).
Investigators at the Cedars - Sinai Heart Institute — whose previous research showed that
cardiac stem cell therapy reduces scarring and regenerates healthy tissue after a heart attack in
humans — have identified components of those
stem cells responsible for the beneficial effects.
Cardiac repair in guinea pigs with
human engineered heart tissue from induced pluripotent
stem cells.
Home - Salk News - Zebrafish study with
human heart implications: Cellular grown - ups outperform
stem cells in
cardiac repair
Neuregulin / ErbB Signaling Regulates
Cardiac Subtype Specification in Differentiating
Human Embryonic
Stem Cells.
Human embryonic
stem cell - derived cardiomyocytes engraft but do not alter
cardiac remodeling after chronic infarction in rats.
• Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant
cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic
stem cell transplant within 100 days before first dose of study drug • Known history of
human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct in primary site or histology from the cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
Researchers have shown that
human induced pluripotent
stem cells can differentiate and self - organize into
cardiac microchambers when spatially confined.
Cardiomyocytes (CMs) derived from
human pluripotent
stem cells (hPSCs) are considered a most promising option for cell - based
cardiac repair.
Researchers are now able to use induced pluripotent
stem cells (iPSC) to form a model of
human adult - like
cardiac muscle by introducing electric and mechanical stimulation at an early stage.